Your browser doesn't support javascript.
loading
[Epidemiological estimation of the effectiveness of the pertussis vaccination during outbreaks in a community. Les pédiatres et bactériologistes du réseau RENACOQ]. / Estimation épidémiologique de l'efficacité de la vaccination anticoquelucheuse au cours d'épidémies en collectivité. Les pédiatres et bactériologistes du réseau RENACOQ.
Baron, S; Grimprel, E; Daurat, G; Cuisinet, C; Ponge, A; Haeghebaert, S; Guiso, N; Desenclos, J C; Drucker, J.
Afiliación
  • Baron S; Réseau national de Santé publique, hôpital Saint-Maurice, France.
Arch Pediatr ; 4(8): 744-50, 1997 Aug.
Article en Fr | MEDLINE | ID: mdl-9337897
ABSTRACT

BACKGROUND:

With the recent pertussis vaccine trials, the efficacy of acellular vaccines is now well known, estimated at 85% for multicomponent vaccines. On the other hand, the estimates of whole cell vaccines efficacy varies from 36% to 98% with the different vaccines used. We evaluated the field effectiveness of the French whole cell pertussis vaccine during outbreaks in schools and centers for disabled children.

METHODS:

Four limited outbreaks between 1993 and 1995 were investigated using a retrospective cohort study design. Vaccine effectiveness (VE) was assessed for the following case definition clinical pertussis, laboratory-confirmed pertussis, epidemiologically confirmed pertussis (documented contact with a laboratory confirmed case). Immunization history was obtained by reviewing the child health record book. Effectiveness of a whole vaccination (four injections) and of a partial vaccination (one to three injections) were estimated as 1-(attack rate among vaccinated/attack rate among non-vaccinated).

RESULTS:

A whole immunization conferred good protection against pertussis with an estimated VE higher than 92% in three surveys, lower in the fourth survey (84%) in which antibiotic prophylaxis was set up very rapidly. A partial immunization conferred a mild protection (median 60%).

CONCLUSIONS:

These results are consistent with a previous report about the effectiveness of this whole cell vaccine using the screening method in a hospital network survey in France. In the same way, a large efficacy trial in Senegal comparing it with an acellular bivalent vaccine estimated its efficacy at 96%. This high efficacy together with a satisfactory vaccine coverage leads to the current epidemiological profile of pertussis in childhood in France majority of cases occurring before 6 months of age, limited outbreaks in school children, many of whom being unvaccinated or partially vaccinated.
Asunto(s)
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacuna contra la Tos Ferina / Tos Ferina / Brotes de Enfermedades / Vacunación Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Humans País/Región como asunto: Europa Idioma: Fr Revista: Arch Pediatr Año: 1997 Tipo del documento: Article País de afiliación: Francia
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacuna contra la Tos Ferina / Tos Ferina / Brotes de Enfermedades / Vacunación Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Humans País/Región como asunto: Europa Idioma: Fr Revista: Arch Pediatr Año: 1997 Tipo del documento: Article País de afiliación: Francia